Zobrazeno 1 - 10 of 78 pro vyhledávání: '"Sameera R, Wijayawardana"'
1
Akademický článek
Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancer
Autor: Michael Crager, Sameera R. Wijayawardana, Aaron M. Gruver, Andrea Blacklock, Christy Russell, Frederick L. Baehner, Francisco Sapunar
Publikováno v: Breast Cancer Research, Vol 24, Iss 1, Pp 1-7 (2022)
Abstract Background The United States Food and Drug Administration recently approved a Ki-67 immunohistochemistry (IHC) assay to identify patients with early breast cancer at high disease recurrence risk. The Oncotype Dx Breast Recurrence Score® ass
Externí odkaz: https://doaj.org/article/29436609f41c471aa39faa948b2588b3
Zobrazit plný text záznamu
2
Akademický článek
RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With EGFR-Mutated Metastatic NSCLC
Autor: Makoto Nishio, MD, PhD, Kazuto Nishio, MD, PhD, Martin Reck, MD, PhD, Edward B. Garon, MD, Fumio Imamura, MD, PhD, Tomoya Kawaguchi, PhD, Hiroyuki Yamaguchi, MD, PhD, Satoshi Ikeda, MD, PhD, Katsuya Hirano, MD, Carla Visseren-Grul, MD, Matteo Ceccarelli, PharmD, MS, Sameera R. Wijayawardana, PhD, Annamaria Zimmermann, MS, Tomoko Matsui, Sotaro Enatsu, MD, PhD, Kazuhiko Nakagawa, MD, PhD
Publikováno v: JTO Clinical and Research Reports, Vol 3, Iss 4, Pp 100303- (2022)
Introduction: Ramucirumab (RAM) plus erlotinib was found to have superior progression-free survival (PFS) versus placebo plus erlotinib in untreated EGFR-mutated metastatic NSCLC in the global phase 3 RELAY study. RELAY+ was an open-label, two-period
Externí odkaz: https://doaj.org/article/2c15ffbd66fc4dc2bedf92f859b0dd3f
Zobrazit plný text záznamu
5
Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study
Autor: Takatsugu Ogata, Yukiya Narita, Zev A. Wainberg, Eric Van Cutsem, Kensei Yamaguchi, Yongzhe Piao, Yumin Zhao, Patrick M. Peterson, Sameera R. Wijayawardana, Paolo Abada, Anindya Chatterjee, Kei Muro
Publikováno v: Journal of gastric cancer, vol 23, iss 2
PURPOSE: Liver metastasis (LM) is reported in approximately 40% of patients with advanced/metastatic gastric/gastroesophageal junction adenocarcinoma (metastatic esophagogastric adenocarcinoma; mGEA) and is associated with a worse prognosis. This pos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a269ab4baff7b9abffcb2c03d41add2e
https://escholarship.org/uc/item/2647c9hc
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje